Cargando…

Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review

Cutaneous lupus erythematosus (CLE) is a group of autoimmune connective tissue disorders that significantly impact quality of life. Current treatment approaches typically use antimalarial medications, though patients may become recalcitrant. Other treatment options include general immunosuppressants...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubov, Janet E., Jamison, Aisha S., Baltich Nelson, Becky, Amudzi, Alice A., Haas, Kelly N., Richmond, Jillian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008762/
https://www.ncbi.nlm.nih.gov/pubmed/35431950
http://dx.doi.org/10.3389/fphar.2022.802624
_version_ 1784687127492034560
author Lubov, Janet E.
Jamison, Aisha S.
Baltich Nelson, Becky
Amudzi, Alice A.
Haas, Kelly N.
Richmond, Jillian M.
author_facet Lubov, Janet E.
Jamison, Aisha S.
Baltich Nelson, Becky
Amudzi, Alice A.
Haas, Kelly N.
Richmond, Jillian M.
author_sort Lubov, Janet E.
collection PubMed
description Cutaneous lupus erythematosus (CLE) is a group of autoimmune connective tissue disorders that significantly impact quality of life. Current treatment approaches typically use antimalarial medications, though patients may become recalcitrant. Other treatment options include general immunosuppressants, highlighting the need for more and more targeted treatment options. The purpose of this systematic review was to identify potential compounds that could be repurposed for CLE from natural products since many rheumatologic drugs are derived from natural products, including antimalarials. This study was registered with PROSPERO, the international prospective register of systematic reviews (registration number CRD42021251048). We comprehensively searched Ovid Medline, Cochrane Library, and Scopus databases from inception to April 27th, 2021. These terms included cutaneous lupus erythematosus; general plant, fungus, bacteria terminology; selected plants and plant-derived products; selected antimalarials; and JAK inhibitors. Our search yielded 13,970 studies, of which 1,362 were duplicates. We screened 12,608 abstracts, found 12,043 to be irrelevant, and assessed 565 full-text studies for eligibility. Of these, 506 were excluded, and 59 studies were included in the data extraction. The ROBINS-I risk of bias assessment tool was used to assess studies that met our inclusion criteria. According to our findings, several natural compounds do reduce inflammation in lupus and other autoimmune skin diseases in studies using in vitro methods, mouse models, and clinical observational studies, along with a few randomized clinical trials. Our study has cataloged evidence in support of potential natural compounds and plant extracts that could serve as novel sources of active ingredients for the treatment of CLE. It is imperative that further studies in mice and humans are conducted to validate these findings. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=251048.
format Online
Article
Text
id pubmed-9008762
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90087622022-04-15 Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review Lubov, Janet E. Jamison, Aisha S. Baltich Nelson, Becky Amudzi, Alice A. Haas, Kelly N. Richmond, Jillian M. Front Pharmacol Pharmacology Cutaneous lupus erythematosus (CLE) is a group of autoimmune connective tissue disorders that significantly impact quality of life. Current treatment approaches typically use antimalarial medications, though patients may become recalcitrant. Other treatment options include general immunosuppressants, highlighting the need for more and more targeted treatment options. The purpose of this systematic review was to identify potential compounds that could be repurposed for CLE from natural products since many rheumatologic drugs are derived from natural products, including antimalarials. This study was registered with PROSPERO, the international prospective register of systematic reviews (registration number CRD42021251048). We comprehensively searched Ovid Medline, Cochrane Library, and Scopus databases from inception to April 27th, 2021. These terms included cutaneous lupus erythematosus; general plant, fungus, bacteria terminology; selected plants and plant-derived products; selected antimalarials; and JAK inhibitors. Our search yielded 13,970 studies, of which 1,362 were duplicates. We screened 12,608 abstracts, found 12,043 to be irrelevant, and assessed 565 full-text studies for eligibility. Of these, 506 were excluded, and 59 studies were included in the data extraction. The ROBINS-I risk of bias assessment tool was used to assess studies that met our inclusion criteria. According to our findings, several natural compounds do reduce inflammation in lupus and other autoimmune skin diseases in studies using in vitro methods, mouse models, and clinical observational studies, along with a few randomized clinical trials. Our study has cataloged evidence in support of potential natural compounds and plant extracts that could serve as novel sources of active ingredients for the treatment of CLE. It is imperative that further studies in mice and humans are conducted to validate these findings. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=251048. Frontiers Media S.A. 2022-03-31 /pmc/articles/PMC9008762/ /pubmed/35431950 http://dx.doi.org/10.3389/fphar.2022.802624 Text en Copyright © 2022 Lubov, Jamison, Baltich Nelson, Amudzi, Haas and Richmond. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lubov, Janet E.
Jamison, Aisha S.
Baltich Nelson, Becky
Amudzi, Alice A.
Haas, Kelly N.
Richmond, Jillian M.
Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review
title Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review
title_full Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review
title_fullStr Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review
title_full_unstemmed Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review
title_short Medicinal Plant Extracts and Natural Compounds for the Treatment of Cutaneous Lupus Erythematosus: A Systematic Review
title_sort medicinal plant extracts and natural compounds for the treatment of cutaneous lupus erythematosus: a systematic review
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008762/
https://www.ncbi.nlm.nih.gov/pubmed/35431950
http://dx.doi.org/10.3389/fphar.2022.802624
work_keys_str_mv AT lubovjanete medicinalplantextractsandnaturalcompoundsforthetreatmentofcutaneouslupuserythematosusasystematicreview
AT jamisonaishas medicinalplantextractsandnaturalcompoundsforthetreatmentofcutaneouslupuserythematosusasystematicreview
AT baltichnelsonbecky medicinalplantextractsandnaturalcompoundsforthetreatmentofcutaneouslupuserythematosusasystematicreview
AT amudzialicea medicinalplantextractsandnaturalcompoundsforthetreatmentofcutaneouslupuserythematosusasystematicreview
AT haaskellyn medicinalplantextractsandnaturalcompoundsforthetreatmentofcutaneouslupuserythematosusasystematicreview
AT richmondjillianm medicinalplantextractsandnaturalcompoundsforthetreatmentofcutaneouslupuserythematosusasystematicreview